• Neutra Corp. is a wellness product development and acquisition company focused on the potential of cannabidiol as a natural therapeutic
• Neutra’s recently acquired Vivis subsidiary has developed a quick absorption soft gel and an athletic use topical cream for CBD consumers
• The sports cream’s development occurs at a time when athletic agencies, such as the World Anti-Doping Agency (WADA) and U.S.A. Triathlon, are taking a more favorable turn toward CBD as a muscle pain therapeutic
• CBD products are expected to drive a multi-billion-dollar market in the United States by 2024, and athletic endorsement could play a significant role in its fortunes

Neutra Corp. (OTCQB: NTRR), a company dedicated to promoting wellness solutions through ongoing research and development, is focusing its energies on several potential acquisitions that are designed to make Neutra a more vertically integrated company capable of competing in the skyrocketing CBD (cannabidiol) market, according to a recent Form 8-K filing (http://ibn.fm/hYmXO).

“Our overall goal is to become a vertically integrated company from cultivation to manufacturing to formulation of products, and then to distribution and retail sales,” CEO Sydney Jim said during a NetworkNewsAudio interview on the company’s direction (http://ibn.fm/CeRW8).

The company markets a pair of CBD products currently under its just-acquired subsidiary VIVIS Corp. — its Hemp Extract Crystalline Soft Gels are designed to provide the most efficient CBD ingestion method available, using a medium-chain triglyceride (MCT) binding agent for rapid absorption in lieu of liquid dilution, and its Hemp Extract Sports Menthol Cream offers transdermal CBD delivery through the skin to battle aches and pains that result from inflammation (http://ibn.fm/dx8iC).

Vivis’ products boast a 99 percent or higher grade of hemp-extracted crystalline CBD.

The early-stage development company plans to utilize a nutraceutical contractor to private label all of Neutra’s products, manufacturing them as the company’s unique brand (http://ibn.fm/wykum). In the meantime, Neutra will also pursue the usual investment avenues for funding its vision of developing natural remedies that promote the body’s ability to heal and maintain itself.

Cannabis researchers BDS Analytics and Arcview Market Research have issued a market forecast that anticipates the collective market for CBD sales in the United States alone will surpass $20 billion by 2024 (http://ibn.fm/I9cGm). The Brightfield Group issued a similar forecast but maintains a more cautionary stance, noting the lack of FDA approval for dietary supplements and food products could reduce the market size to only $4.4 billion by 2022. But granted that the market size was $0.6 billion last year, even the minimum increase is significant (http://ibn.fm/RqzbU).

Acceptance by the enormous professional sports machine could drive a sea change in revenues. A number of pro athletes and former athletes already own interests in CBD product companies, and have spoken out about the potential benefits of using it to manage muscles and joint complaints. Although the non-intoxicating compound is currently still banned by the National Football League (NFL) and the National Basketball Association (NBA), athletes have reserved expectations that the policies may eventually change (http://ibn.fm/e4xqL).

U.S.A. Triathlon made news this month as the first national governing body of an American sport to make a sponsorship deal with a company that sells products containing CBD. Some privately controlled sports organizations have also forged relationships with CBD companies, but U.S.A. Triathlon is a national governing body of an Olympic sport that must abide by the World Anti-Doping Agency’s (WADA’s) regulations for international competition. However WADA removed CBD from its list of banned substances last year, opening the door for elite athletes to use and endorse CBD products (http://ibn.fm/v3Do5).

Rocky Harris, chief executive of U.S.A. Triathlon, commented on the sponsorship deal that “Athletes prefer not to take prescription drugs. They want organic and healthy. They want to find something more natural.”

“We’re definitely hitting the market at the best possible time,” Jim stated in a news release about Neutra’s sports cream production (http://ibn.fm/g8cNz). “With one in five Americans participating in a sport or exercising regularly, there’s going to be a lot of interest in our product, especially when our cream will be consistency and potency assured by third-party testing. That’s a key market differentiator consumers will appreciate.”

For more information, visit the company’s website at www.NeutraInc.com

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at  http://ibn.fm/NTRR

• The U.S. CBD market is expected to grow to $22 billion by 2022
• CBD extraction from hemp biomass is proving to be the preferred method due to its relatively low cost and high yields in comparison to cannabis extraction
• HTC Extraction Systems has already positioned itself for market success due to its proprietary extraction technology

The CBD extraction market will register exponential growth in the years to come, market reports suggest. According to a Cannabis Extract Market Size report, the annual growth rate for CBD extraction is set at 22.1 percent and the market is anticipated to reach $23.7 billion by 2025 (http://ibn.fm/3leiZ).

Market dynamics will largely drive the demand for high quality extracts up. The world is already seeing steady growth in the need for oils and tinctures derived from hemp biomass. Additionally, legislative changes are liberalizing the market and allowing for large scale operations to be set up easily.

The U.S. CBD market alone will soar from $591 million in 2018 to a massive $22 billion by 2022, growing at a CAGR of 147 percent (http://ibn.fm/Ud2ai). According to reports, this exponential growth will provide excellent opportunities for CBD extraction companies – a player that isn’t spoken of as often as other industry entities are.

Handling the extraction of CBD from hemp biomass is much cheaper and a more effective process than extraction from cannabis. Extraction service providers who are already well-established can easily take on new clients, signing supply agreements that last for several years. Hence, this market segment is considered quite promising and crucial for the overall development of the industry.

Companies like HTC Extraction Systems (TSX.V: HTC) are already capitalizing on their market presence established through the development of innovative extraction technologies.

HTC Extraction Systems has developed a proprietary ethanol, solvent and glycol reclamation operation. The company’s biomass processing methodology is utilized in three stages – pre-oil preparation, oil extraction and purification and oil refinement. The result is 50 percent crude CBD oil that can be distilled further for the production of full spectrum oil or pure CBD isolate.

HTC is engaged in preliminary due diligence investigations that would expand its operations into the United States, where the company seeks to replicate its model of using hemp biomass tolling contracts with producers and other providers to begin extraction for the 2020 hemp crop growing year in an as-yet-to-be-determined location.

The company has entered into and are negotiating various agreements that will continue to strengthen its hemp biomass processing potential. Based on one agreement alone, HTC Extraction Systems will process five million kilograms of Identity Preserved hemp biomass to extract full spectrum oil and/or pure CBD isolate.

The company’s operations have generated a three-fold revenue hike – from $560,260 in 2018 to $1.85 million over the course of 2019 so far.

During the same period, HTC Extraction Systems announced its already developed strategy for extracting cannabidiol full spectrum oil from hemp biomass for distillation. The company’s patented Delta Purification System offers high quality environmental reclamation technology for clean biomass extraction. Upon receipt of required license and the implementation of the company’s intellectual property through the extraction system, HTC Extraction Systems will have hemp biomass byproducts available for singulation and CBD pharmaceutical market sales.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• HTC Extraction Systems is advancing its strategy to use its ethanol-based distillation know-how to extract and refine cannabidiol full spectrum oil in Canada and the United States
• The company’s proprietary Delta Purification system and DeltaSolv technologies will be housed in a Saskatchewan biomass processing facility, with a future second facility anticipated in the United States
• HTC closed a bought deal agreement on October 22 worth $10 million in funding for the company’s operations
• The company reported unaudited interim condensed consolidated financial results in August that showed the company experienced a three-fold increase in revenue for the year

HTC Extraction Systems (TSX.V: HTC) is advancing its plans to become one of the largest extraction, distillation and refining operators in North America in the market for fully integrated hemp, cannabidiol (CBD) and other cannabinoid products following the closing date for a bought deal agreement that is set to add C$10 million in aggregate gross proceeds to HTC’s coffers.

HTC has developed and subsequently improved on proprietary systems for biomass, gas and liquid extraction, founded on the distillation of ethanol and ethanol-based solvents used in the extraction process. The company is developing an extraction, distillation and refining strategy that derives hemp biomass product from farmers through tolling contracts in Canada and anticipated opportunities in the United States.

HTC has built a 19,000-square-foot extraction facility in Port Lajord, Saskatchewan, near the metropolitan Regina commerce center. The facility will provide the commissioning for newly installed biomass processing, extraction, distillation and refining equipment, utilizing the corporation’s DeltaSolv™ technologies and Delta Purification® systems.

The facility will also house laboratory quality control and testing operations, as well as on-site administration offices. HTC is also engaged in preliminary due diligence investigations that would expand its operations into the United States, where the company seeks to replicate its model of using hemp biomass tolling contracts with producers and other providers to begin extraction for the 2020 hemp crop growing year in an as-yet-to-be-determined location.

The company will ensure tolling and processing volumes by selecting qualified harvest contractors and using diversified growing locations, high performance regulated genetics and irrigation to establish two or three annual crop rotations, according to a recent company statement (http://ibn.fm/dVg6j).

The brokered private placement “bought deal” with Canaccord Genuity Corp. involves 25 million units of combined common shares plus warrants to purchase further common shares at a price amended to C$0.40 per unit (http://ibn.fm/KdjAA). Canaccord is a global, full-service investment bank focused on growth companies, and the sole bookrunner and lead underwriter on behalf of a syndicate of underwriters for the bought deal.

Upon receipt of required licenses, HTC’s existing operation in Canada includes receiving a projected five million kilograms of hemp biomass from this year’s Saskatchewan harvests, using five varieties of Health Canada-approved cultivars as the genetic foundation. The tolling agreement allows HTC to extract CBD full spectrum oil (FSO) and to keep a percentage of the distillate as payment of the tolling fee.

The company plans to use the CBD FSO distillate in sales and offtake agreements with its related entity, Purely Canada Foods, through which it will sell and distribute its CBD to Purely Canada Foods’ customers under the brands Purely Canada Hemp, Purely Canada CBD, Purely Canada Cannabinoids and Purely Canada THC. The hemp byproducts will also be available for expected singulation and sale to the cannabinoid pharmaceutical market.

In August, the company posted unaudited interim condensed consolidated financial results that showed the company experienced a three-fold increase in revenue during the previous year (http://ibn.fm/M9XcB). HTC’s carbon dioxide extraction business and fertilizer and grain handling operations drove revenues from $560,260 in 2018 to $1.85 million this year.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• Telco capital expenditures of $150 billion are planned through 2023
• Aerospace companies are also spending on 5G
• Spectrum recently secured a key, two-year nationwide contract with a Tier-1 infrastructure aggregator

It’s not just telecommunications companies that are opening their businesses – and wallets – to 5G. Space companies are investing in 5G technology too, which means good things for companies such as Spectrum Global Solutions Inc. (OTCQB: SGSI). Lured by the faster speeds and lower latencies of 5G, Boeing, SpaceX and other aerospace companies hope to increase the range of telecommunications possible through satellite, which is good enough for phone calls and TV but can’t handle data-intensive applications like streaming video – à la Netflix – very well.

Harnessing those advantages, however, requires investment in costly new innovations. As a result, what started as a trickle of dollars for 5G infrastructural development has now turned into a flood. That influx of funds means infrastructure aggregator Spectrum can look ahead to a bright future as it continues to build and service end-to-end communications networks at home and abroad.

It may seem strange that aerospace companies are venturing into 5G. But some of those companies build telecommunications satellites, and anything that increases satellite capability, such as 5G, is good for business. New technologies such as electronic product codes (EPC), data orchestration and 5G New Radio are bringing 5G closer to the masses.

An EPC is a unique identifier for physical objects that can be used to track the object in a supply chain. EPCs are designed to be stored on a radio-frequency identification (RFID) tag and may be associated with dynamic data such as the origination point of an item or the date of its production. Data orchestration is the automation of data-driven processes to achieve an integrated workflow. 5G New Radio (NR) is the global standard for the 5G wireless air interface, or the radio-frequency portion of the connection between a mobile phone and the cell tower. 5G NR opens up the spectrum above 6 GHz, which was previously unusable by cellular services.

The rollout of 5G networks is expected to create three million American jobs and add half a trillion dollars to U.S. GDP, according to global-management consultant Accenture. Spectrum has already been selected to play a part, based on its global track record of successfully executing more than 150,000 projects. Since commencing operations 34 years ago, the company has delivered cost-effective, scalable, robust solutions for communication carriers, utilities, enterprise companies, OEMs and others. And as 5G infrastructure spending increases, SGSI’s opportunity pipeline has swollen to $137 million.

Spectrum serves the biggest and the best in the industry including major carriers such as AT&T, Sprint, T-Mobile and Verizon; aggregators such as American Tower, Crown Castle, Zayo and ExteNet; and big-name OEMs such as Ericsson, Nokia and Samsung. The company’s longstanding relationships generate repeat business at minimal acquisition cost. As the shift to 5G progresses, telecom CAPEX upgrades are forecast to hit $150 billion by 2023.

As evidence of the potential, Spectrum recently won a key two-year nationwide engineering services contract to support the 5G network deployment initiatives of a Tier-1 infrastructure aggregator. The contract is for outside plant engineering services surrounding an optical fiber-fed, 200-plus site, metropolitan-area, 5G infrastructure deployment (http://ibn.fm/JBap4).

“We are pleased to announce another Tier-1 contract win supporting the rollout of a 5G network in a major metropolitan area in the United States,” Spectrum Global Solutions President Keith Hayter stated in a news release. “We continue to see ramping demand for our services to power the 5G connectivity revolution, the infrastructure spending for which we expect to continue unabated for the next several years.”

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI

• ChineseInvestors.com  CEO recently discussed its corporate initiatives in a MoneyTV segment
• The company’s subsidiary, CBD Biotech, has expanded into seven strong Asian markets
• ChineseInvestors.com offers a diverse menu of investor education products and services

ChineseInvestors.com Inc. (OTCQB: CIIX) has become a foremost financial information website for Chinese-speaking investors around the world. Through its main website, www.ChineseInvestors.com, it provides an array of investor education products and services. In addition, the company’s CBD division, CBD Biotech Inc., has experienced tremendous growth. Recently, CIIX CEO Warren Wang discussed the focus of the company on MoneyTV with Donald Baillargeon (http://ibn.fm/vxRIS). In an effort to maximize transparency with investors, Wang provided an overview of the company’s two business strands.

Wang noted that CIIX’s main business, accounting for 60-70 percent of its revenue streams, is its investor relations business. This segment of the company offers a variety of services to clients. With a main office in New York, its experienced executive team is headed by service director Angel Feng. Over the last six years, ChineseInvestors.com has accrued close to 100 IR (investor relations) clients, organized road shows, launched its own television channel with Phoenix TV, conducted radio shows, and managed social media platforms.

Wang notes that ChineseInvestors.com helps its clients expand their shareholder base. Additionally, the company’s subscription division, a live broadcast set during market hours, allows members to connect with professors who are experienced in navigating the stock market. He added that members enjoy this interactive program and appreciate the education provided in how to trade options on the market. This valuable program is enabling ChineseInvestors.com to build its customer and investor database.

While the company continues to roll out new products and services, its present plan is to emphasize its original mission of providing financial information and services to the larger Chinese community in the United States and elsewhere (http://ibn.fm/jvr8b). With offices in San Gabriel, California; Flushing, New York; and Shanghai, China, ChineseInvestors.com is well-positioned to achieve this goal. “While we have been strategically focusing on industrial hemp and CBD sales, we are pleased with the progress we have seen in our legacy businesses, financial news, education subscriptions, and investor relations, where we are re-focused on organic growth,” Wang said recently.

In reference to the company’s rapidly growing CBD division, the company hopes for a Nasdaq IPO of CBD Biotech late in FY2019 or early in 2020. Moreover, the company’s CBD Biotech subsidiary has expanded into six new countries and a new region of China (http://ibn.fm/JP23E) and is laying a foundation to capitalize on growing demand for CBD-based nutrition and health products. Growth via acquisition will be a priority following an initial public offering spin-off of CBD Biotech (http://ibn.fm/g9Uvp).

On the MoneyTV segment, Wang also discussed how the company’s stock price has stabilized because of enhanced communication between company leaders and the company’s mainstream shareholders. Referencing the OTC market, Wang described it as a “very liquid market,” noting that volumes can be quite diverse from day to day. However, referencing American business magnate Warren Buffet, Wang described Buffet seeking out the OTC market first when considering an investment as the OTC is a “value stock vehicle.” Wang’s goal is that the market will recognize the significant value in ChinesInvestors.com. He wished his investors the best, hoping they will be patient with all the company is working to accomplish.

For investors, ChineseInvestors.com offers a window of opportunity for ROI with its two-pronged approach to growth and profits. This past June, company leaders anticipated CIIX doubling it sales over the next year. ChineseInvestors.com continues to focus on becoming the top financial information website for Chinese-speaking investors globally.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• SRAX’s CEO presented at the Microcap Rodeo Investor Conference held October 15 in Austin, Texas
• The company’s BIGtoken offers an innovative way for consumers to own and earn from their data
• The company aims to become a household name in the data management sector

SRAX Inc. (NASDAQ: SRAX) CEO Christopher Miglino presented at the Microcap Rodeo Investor Conference held at the Hilton Austin Downtown in Austin, Texas on October 15. The theme of the conference, ‘Lassoing the Best Ideas’, aptly encompasses SRAX. SRAX’s innovative strategy to solve the problem of consumer consent to release data is aiding it in its quest to build the largest opted-in data set in the world.

SRAX’s innovative BIGtoken platform requests permission from its users for data sharing when those users sign up on the platform (http://ibn.fm/LbKG2). SRAX is ahead of the competition in using this approach. In California, a new privacy law compliance bill goes into effect January 1, 2020, requiring users to provide this permission before their information can be shared. The law is designed to protect the privacy of consumers, a responsibility SRAX has taken seriously since the inception of its BIGtoken app.

A recent CNBC report noted that the legislation could mean that some firms may have to pay in aggregate up to $55 million in initial compliance costs, according to an assessment prepared by an independent research firm for the state attorney general’s office in California (http://ibn.fm/LrIWb). Thanks to BIGtoken, SRAX is already in compliance with the legislation.

SRAX is a digital marketing and consumer data management technology company that has developed a first-of-its-kind data management platform. The company’s proprietary BIGtoken platform offers a secure and transparent environment for consumers to own and earn from their data (http://ibn.fm/jXGBN). The SRAX product offers consumers key control over their own privacy and also unlocks the value of their data. The Microcap Rodeo Investor Conference (http://ibn.fm/pYQAc) offered investors the firsthand opportunity to hear details about BIGtoken and the company’s strategy from Miglino himself.

The annual Austin conference offers investors the chance to harness top stocks for their portfolios. Executive management teams from more than 50 microcap companies across a wide variety of industries attended this year’s event, which featured four tracks of diverse company presentations along with an interactive, in-depth format of face-to-face meetings.

SRAX’s technology dually benefits both individual consumers and the companies seeking to utilize their data. For the latter, SRAX sells access to data in the form of anonymized segments. BIGtoken unlocks data to reveal the core customers of brands and the characteristics of those consumers across marketing channels. Individual consumers utilize the BIGtoken platform to control access to their information at any time. By creating a mutually beneficial way to help consumers market themselves while also protecting their privacy, the company is building the largest and most valuable opted-in data set worldwide. Through the added exposure gained from Miglino’s appearance at the Microcap Rodeo Investor Conference, the company is poised to become a household name in the data management sector.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at  http://ibn.fm/SRAX

• TGOD is the only licensed producer to grow certified organic cannabis at scale
• The Green Organic Dutchman’s processes are certified by two of the largest organic certification organizations in the world
• The company’s certified-organic process benefits consumers, the community and the environment

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), a global leader in cultivating premium, certified organic cannabis, prides itself on its commitment to producing premium organic cannabis. The company is the only Licensed Producer to grow certified organic cannabis at scale. Maintaining that commitment isn’t easy, but TGOD’s higher standard of organic growing has attracted a strong base of customers who value being able to trust that their products are cultivated in accordance with Canadian organic standards and are not irradiated.

TGOD’s decision to go organic is rooted in the company’s desire to provide its consumers with the highest-quality, healthiest options on the market. The Green Organic Dutchman understands that, for many, cannabis is a life-changing medicine. Patients and consumers alike have no desire to ingest irradiated products.

In addition, research indicates that more than 55 percent of Canadian consumers purchase organic products on a weekly basis, and over 80 percent of those maintained – or increased – their organic purchases in the last year. With that kind of consumer base, along with organic trends growing around the world and its dedication to providing only the best, TGOD’s decision to go organic was a no-brainer.

Growing certified-organic cannabis doesn’t just benefit consumers. The process is also better for the community, the soil and the environment. TGOD’s cultivation process includes creating a living soil designed to build a population of beneficial organisms that provide an enhanced diversity of biology in the soil. That means that when TGOD “hands over the power to the flower,” the plant teams up with the right fungi and healthy bacteria to grow the highest-quality cannabis available.

In an era where the term “organic” is often thrown about casually, clients appreciate knowing that TGOD’s organic claims are officially recognized. TGOD’s processes are certified by both ECOCERT and Pro-Cert, two of the largest organic certification organizations in the world. ECOCERT standards are based on natural and organic principles, including the use of ingredients derived from renewable resources and environmentally friendly process. Pro-Cert’s certification is ISO 17065 compliant and accredited.

While TGOD is committed to being a global leader in certified organic cannabis, the company’s goal is also to create a positive economic impact locally. The company’s community farm produces fresh organic food that it contributes through food donation programs. Finally, because growing organically focuses on the natural growth of the plant, it is a cleaner process. Through its regenerative farming practices, TGOD also reduces its carbon footprint throughout the entire product life cycle.

The Green Organic Dutchman is a publicly traded, premium-cannabis producer in Canada, engaged in growing organic cannabis using craft farming techniques. The company operates in medical cannabis markets in Canada, Europe, the Caribbean, and Latin America, and also supplies to the Canadian adult-use market. TGOD also operates in the CBD-oil markets of Canada and distributes premium-hemp CBD oil in the European Union through its wholly owned subsidiary HemPoland.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at  http://ibn.fm/TGODF

• VPR Brands commissioned a report outlining where 2020 presidential hopefuls stand on legalizing cannabis in an effort to promote a strong cannabis industry
• The company continues to execute its growth plan by adding products, adding customers and increasing sales
• VPR Brands recorded an increase in quarterly revenues, a lowered net loss and a strong gross operating margin

As America looks toward the 2020 election, one key issue is weighing on the minds of companies and employees within the cannabis industry. Which candidates seek to make cannabis legal and to see the industry thrive?

VPR Brands LP (OTCQB: VPRB), a technology holding company specializing in vaporizers and accessories for essential oils, cannabis concentrates, extracts, and electronic cigarettes containing nicotine, shows revenue and product potential to compete with larger companies on the OTC in the cannabis sector. The company’s Q1 2019 report (http://ibn.fm/6WVql) announced a 31 percent year-over-year increase in quarterly revenues, a lowered net loss, and a strong gross operating margin above 40 percent. As VPRB continues to invest in inventory and new products to keep up with increased demand, it is only natural that its leadership keep a close eye on the presidential debate stage.

Kevin Frija, the CEO of VPRB, commissioned a report (http://ibn.fm/IXAzA) to outline where the 2020 presidential hopefuls stand on this critical issue. Journalist William Freedman was sponsored by VPRB to investigate what the nearly 30 candidates have been saying and doing about cannabis’ future in America. The purpose of the report was to provide clear, factual data to voters interested in the cannabis industry.

The resulting landmark study, titled ‘The VPR Brands Voters’ Guide to 2020 U.S. Presidential Candidates on Cannabis Issues’, can be read in its entirety at www.VPRBrands.com/Cannabis-Vote-2020.

As the cannabis industry continues to flourish and grow, becoming a major contributor to both local and global economies, political figures can no longer afford to ignore or demonize it. Indeed, this is the first presidential election where candidates have been willing to take on controversial public positions on cannabis issues, and many are utilizing all avenues to do so: from the presidential debate stage to their personal social media accounts. On October 15, 2019 in the middle of the Ohio democratic debate, Beto O’Rourke tweeted, “Legalize marijuana” (http://ibn.fm/JG5Hs) with a follow-up image promoting legalization (http://ibn.fm/H2xQg).

A light-hearted exchange (http://ibn.fm/OG6Re) between Cory Booker and Bernie Sanders where the latter joked he was not “on [medicinal marijuana] tonight” further highlights the shifting public attitudes toward the burgeoning industry that was once marginalized to shadowy back alleys. As big pharmaceutical companies are coming under fire for the growing opioid crisis, people and politicians are looking to cannabis as part of the solution (http://ibn.fm/j1UNy).

VPRB’s commissioned report outlined four cultural shifts in America in regard to cannabis over the past decade. They are:

1. Acceptance of CBD and THC for both medical and recreational use
2. Recognition that the laws prohibiting their sale and possession might be disproportionate to the harm to society
3. Acquiescence in one-time tobacco-growing states that industrial hemp could serve as a replacement cash crop
4. Realization that no business can be fully legitimized until banks can provide it financing without fear of losing their federal charters

Reexamination of cannabis policy at the federal level is necessary for the industry to thrive. As the federal government catches up, VPRB continues to drive growth by adding products, adding customers, and increasing sales. In 2019 a major growth initiative has been to drive revenue through ecommerce, which has brought in approximately 10 period of VPRB’s total revenue. They continue to seek out strategic partnerships, drive organic customer growth, and stay on the forefront of innovation.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at  http://ibn.fm/VPRB

• Lexaria Bioscience Corp. continues to make progress in the patenting and development of its DehydraTECH™ platform
• Lexaria developed the patented DehydraTECH™ drug delivery platform as a safer alternative to inhalation of nicotine or cannabinoids
• DehydraTECH™ has been shown to facilitate rapid uptake and highly targeted delivery of pharmaceuticals to the brain

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has levered innovation, research and development into operations in four market verticals: cannabis, hemp, nicotine, and pharmaceuticals. Lexaria already introduced the DehydraTECH™ drug delivery platform into commercial use and has a second-generation delivery platform ready for launch in 2020. Lexaria is the only company in the world to receive a patent for this improved oral delivery of all non-psychoactive cannabinoids including CBD. In fact, the company has 16 patents already granted along with more than 60 patents that are pending worldwide (http://ibn.fm/j08G0).

Lexaria has cannabinoid licensing agreements with various companies in North America. The popularity of cannabinoid products such as CBD is likely to increase in the future and the U.S. cannabis market alone is projected to grow substantially in the future (http://ibn.fm/LsBtn). Lexaria’s delivery technology is already being used by the CBD/hemp industry and could experience radical growth in step with the industry.

The DehydraTECH™ drug delivery platform is an innovative technology that was developed as a way to safely and effectively deliver substances both to the bloodstream and to the brain via the oral ingestion route. Substances such as nicotine and cannabidiol are historically inhaled, a choice that is harmful to health compared with non-inhalation methods.

Inhalation can be problematic and dangerous especially for individuals who may have other medical issues. The DehydraTECH™ drug delivery platform can be used to deliver substances in edible or in beverage form, and in capsules, pills, syrups and more. Brands in both Canada and the USA have licensed DehydraTECH™ to make their CBD and cannabis beverages best-in-class.

Not only is ingestion a much safer form of drug delivery, but DehydraTECH™ also delivers the active ingredient of the substance at a rate that is up to five to ten times faster compared with traditional edible products. A 2018 European clinical study demonstrated that 317 percent more CBD was delivered within half an hour when compared with a positive control of equal strength (http://ibn.fm/pXIxY). The substance being delivered is also rapidly absorbed which means that people can achieve the effect they are looking for more quickly than was previously the case with edibles. For people looking for quick relief of pain, DehydraTECH is a blessing.

Many human receptor cells are clustered primarily in the brain or central nervous system, so in order to treat conditions, drugs need to effectively reach these areas of the body which has historically been difficult to do. Research studies done with animals have demonstrated delivery of 1,937 percent more cannabidiol (and over 500 percent more nicotine) into the brain tissue after 8 hours when using the enhanced DehydraTECH™ when compared with using generic industry MCT coconut-oil formulations. Greater effectiveness can mean safer, lower doses. The increased bioavailability and speed of onset are important factors when delivering substances to the brain and is especially important for people who need rapid relief from unpleasant and debilitating symptoms.

Studies done in the laboratory have also shown dramatically improved oral nicotine delivery using the DehydraTECH™ platform. Lexaria has partnered with one of the world’s largest tobacco companies to help fund the research and development of DehydraTECH™ as it relates to nicotine delivery (http://ibn.fm/rlVJn).

A big advantage of the DehydraTECH™ drug delivery platform when it comes to nicotine is that the delivery is fast when compared with other oral forms of nicotine – such as nicotine lozenges or nicotine gum. Users are less likely to get frustrated if they can feel the effects of the nicotine faster when taken in through the oral route. Lower-risk technologies are needed when it comes to nicotine, which is something that the government has recognized since smoking is known to be deadly. Therefore, technology developed to reduce health risks is highly beneficial.

DehydraTECH™ drug delivery platform has applications for the pharmaceutical industry and could be used to deliver fat-soluble drugs. It also could be used to deliver NSAID medications such as ibuprofen or acetylsalicylic acid. DehydraTECH™ has the advantage of allowing substances to bypass first phase liver metabolism.

The technology uses GRAS (Generally Recognized As Safe) food ingredients and further advantages are that the technology removes the bitter flavors and odors of many drugs. This is beneficial because artificial sweeteners do not need to be added to the product to enhance its taste and make it palatable. Sugar may be an issue, especially for people who have diabetes, thus a sugar-free product would be a healthier option.

Lexaria was recently granted two granted patents related to the treatment of heart disease, Alzheimer’s, Parkinson’s and schizophrenia. The treatment of these and other types of neurological disorders in particular has been problematic due to the blood-brain barrier – which makes it difficult for the brain to take up the needed medications. This barrier is formed by endothelial cells which function to prevent dangerous substances from passing into the brain from blood vessels, but the problem is that this also often stops helpful drugs from being able to enter the brain. The patented DehydraTECH™ drug delivery platform helps overcome this limitation to rapidly deliver essential medications to the brain.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at  http://ibn.fm/LXRP

• B2Digital files Form 8-A Registration Statement with SEC; it is now subject to SEC reporting requirements
• The filing enhances B2Digital’s accountability while contributing to increased liquidity
• Three key acquisitions mark B2Digital’s steady progress toward becoming a premier live-event sports company

With an extensive background in entertainment, television, video and technology, B2Digital Inc. (OTC: BTDG) is in the process of developing and acquiring MMA and sports-related companies to become a premier, vertically integrated, live-event sports company. B2Digital took a significant step in that process when it recently filed a Form 8-A Registration Statement with the U.S. Securities and Exchange Commission (SEC) and is now fully reporting.

“We believe that becoming a fully-reporting company subject to the reporting requirements of the SEC shows our commitment to providing current public information to not only our deserving and valued shareholders but to the public, in general,” B2Digital chairman and CEO Greg P. Bell stated in a news release. “Being a fully reporting company with the SEC should also help contribute to increased liquidity for our current and future shareholders and will enhance management’s accountability.”

The SEC filing means that BTDG is now subject to the reporting requirements of the Exchange Act of 1934 as amended, including Form 10-K, Form 10-Q and Form 8-K reporting requirements, as well as additional reporting obligations related to proxies, shareholder actions and stock ownership.

The SEC filing is only the latest in a several milestone moments for B2Digital this year. The company has announced three key acquisitions this year, including the following:

• United Combat League (http://ibn.fm/yhO3P): Through this acquisition, the company acquired four top MMA companies. The United Combat League operates fights in Illinois and Wisconsin.
• Pinnacle Combat (http://ibn.fm/eayag): With this move, B2Digital acquired five top MMA companies. Pinnacle Combat hosts fights in Iowa.
• Strike Hard Productions of Alabama: BTDG recently acquired its sixth top MMA company, Strike Hard Productions, who has held more than 50 LIVE MMA events in Alabama and Mississippi.

With these acquisitions, B2Digital’s B2 Fighting Series brand now includes HRMMA, Colosseum Combat, United Combat League, Pinnacle Combat and StrikeHard Productions fighting companies, as well as MMA news and social media system, Blue Grass MMA. By the end of March 2020, B2 Fighting Series will have scheduled fights in 10 states across the country.

B2Digital is clearing forging toward its goal of becoming a full-service, live-event sports company. Capitalizing on the power of Bell’s expertise and involvement with more than 40,000 live events over his career in major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated premier development league for the multibillion-dollar mixed martial arts industry.

B2Digital also plans to create and develop league champions that will move on to the MMA major leagues from the company’s B2 Fighting Series brand. In addition, B2Digital has deployed its B2 Social Media Network (B2SN) for the B2 Fighting Series. The revolutionary network surpassed 3.8 million social media connections in fiscal Q2 2019, including 64,543 unique users. Those numbers mark the largest audience on B2Sn since the network was launched.

Finally, B2Digital has developed and deployed the systems and technologies for the operation of social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems.

For more information, visit the company’s website at www.B2DigitalOTC.com

NOTE TO INVESTORS: The latest news and updates relating to BTDG are available in the company’s newsroom at http://ibn.fm/BTDG